A new study shows GLP-1 receptor agonists increase pre-meal fullness by activating neurons in the dorsomedial hypothalamus. This mechanism helps prevent overeating, offering insights into obesity treatment. The research highlights how GLP-1 impacts food perception and hypothalamic responses to food cues, enhancing satiation before food intake.
Ozempic Boost Fullness Pre-Meal via Hypothalamus
![](http://sshop.me/wp-content/uploads/2024/06/glp1-thalamus-hunger-block-neurosicence-1155x770-1.jpg)